Unfortunately, the National Highway Traffic Safety Administration reports that about every 39 minutes, someone dies from a drunk-driving accident
Side effects are few but it can cause mild nausea if taken in large doses
BPC 157 peptide appears to break this cycle by stimulating the growth of new blood vessels into the injured area
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide) carry the clinical evidence: STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Typically, you start on the same dose each week for 4 weeks, then gradually increase the dose after reviewing any side effects and results with your healthcare provider